Top

International Journal of Emergency Medicine

Published in:

Open Access 01-12-2020 | Hyperemesis Gravidarum | Case report

Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review

Authors: Julien Flament, Nathan Scius, Henri Thonon

Published in: International Journal of Emergency Medicine | Issue 1/2020

Abstract

Background

Cannabis use is on the rise. Several cases of cannabinoid hyperemesis syndrome, secondary to chronic cannabis intoxication, have been described worldwide, but few cases have described this entity in pregnant women.

Case presentation

We describe a 29-year-old pregnant patient that had consumed cannabis and experienced uncontrolled vomiting. The use of hot baths, the rapid improvement in symptoms, and results of complementary examinations suggested a diagnosis of cannabinoid hyperemesis syndrome. The patient could return home, and she continued her pregnancy and childbirth without peculiarities.

Conclusion

Cannabinoid hyperemesis syndrome should be considered in the differential diagnosis of vomiting in pregnancy. Consumption of cannabis must be systematically included in the anamnesis. However, it seems to be somewhat unacceptable socially or medically. Consumption must be stopped to manage symptoms.

Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004. https://doi.org/10.1136/gut.2003.036350.

Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc. 2012. https://doi.org/10.1016/j.mayocp.2011.10.005.

INCB. World drug report 2014, http://www.incb.org/documents/Publications/AnnualReports/AR2018/Annual_Report/Annual_Report_2018_F.pdf. Accessed April 1, 2020.

Desjardins N, Stheneur C. Cannabinoid hyperemesis syndrome: a review of the literature. Arch Pediatr. https://doi.org/10.1016/j.arcped.2016.01.016.

Nourbakhsh M, Miller A, Gofton J, Jones G, Adeagbo B. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases. J Forensic Sci. 2019. https://doi.org/10.1111/1556-4029.13819.

Goodwin TM. Hyperemesis gravidarum. Clin Obstet Gynecol. 1998. https://doi.org/10.1097/00003081-199809000-00014.

Niebyl JR. Nausea and vomiting in pregnancy. N Engl J Med. 2010. https://doi.org/10.1056/NEJMcp1003896.

Schmid SM, Lapaire O, Huang DJ, Jürgens FE, Güth U. Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy. Arch Gynecol Obstet. 2011. https://doi.org/10.1007/s00404-010-1811-8.

Alaniz VI, Liss J, Metz TD, Stickrath E. Cannabinoid hyperemesis syndrome: a cause of refractory nausea and vomiting in pregnancy. Obstet Gynecol. 2015. https://doi.org/10.1097/AOG.0000000000000595.

10.

Andrews KH, Bracero LA. Cannabinoid hyperemesis syndrome during pregnancy: a case report. J Reprod Med. 2015;60(9-10):430–2.PubMed

11.

Manning Meurer M, Chakrala K, et al. A case of cannabinoid hyperemesis syndrome with Heliobacter pylori and preeclampsia during pregnancy. Subst Abus. 2018. https://doi.org/10.1080/08897077.2017.1356790.

12.

Kim HG, Moon J, Dixon H, et al. Recurrent nausea and vomiting in a pregnant woman with chronic marijuana use. Case Rep Obstet Gynecol. 2018. https://doi.org/10.1155/2018/9746062.

13.

Roberson EK, Patrick WK, Hurwitz EL. Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai'i. Hawaii J Med Public Health. 2014;73(9):283–7.PubMedPubMedCentral

14.

Carlini EA. The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol (Delta 9-THC) on humans. Toxicon. 2004;44(4):461–7.CrossRefPubMed

15.

Westfall RE, Janssen PA, Lucas P, et al. Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'. Complement Ther Clin Pract. 2006;12(1):27–33.CrossRefPubMed

16.

Russo E. Cannabis treatments in obstetrics and gynecology: a historical review. J Cannabis Therapeut. https://doi.org/10.1300/J175v02v03_02.

17.

Gebeh AK, Willets JM, Marczylo TH, et al. Plasma anandamide and related n-acylethanolamide levels are not elevated in pregnancies complicated by hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2014. https://doi.org/10.3109/14767058.2013.847413.

18.

Keegan J, Parva M, Finnegan M, Gerson A, Belden M. Addiction in pregnancy. J Addict Dis. 2010. https://doi.org/10.1080/10550881003684723.

19.

Jaques SC, Kingsbury A, Henshcke P, Chomchai C, Falconer J, Abdelatif ME, et al. Cannabis, the pregnant woman and her child: weeding out the myths. J Perinatol. 2014. https://doi.org/10.1038/jp.2013.180.

20.

Fejzo MS, Trovik J, Grooten IJ, Sridharan K, Roseboom TJ, Vikanes A, et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Primers. 2019. https://doi.org/10.1038/s41572-019-0110-3.

21.

O'Donnell A, McParlin C, Robson SC, Beyer F, Moloney E, Bryant A, et al. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment. Health Technol Assess. 2016. https://doi.org/10.3310/hta20740.

22.

Sun S, Zimmermann AE. Cannabinoid hyperemesis syndrome. Hosp Pharm. 2013. https://doi.org/10.1310/hpj4808-650.

23.

Hickey JL, Witsil JC, Mycyk MB. Haloperidol for treatment of cannabinoid hyperemesis syndrome. Am J Emerg Med. 2013. https://doi.org/10.1016/j.ajem.2013.02.021.

24.

Reference Center for Teratogens, https//lecrat.fr. Accessed April 1, 2020.

25.

Dezieck L, Hafez Z, Conicella A, Blohm E, O’Connor MJ, Schwarz ES, et al. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series. Clin Toxicol (Phila). 2017. https://doi.org/10.1080/15563650.2017.1324166.

26.

Elkin K, Tai P, Winkel J, Kulkarni M, Sadler D, Truong N, et al. 337 Cannabinoid hyperemesis syndrome: 3-year practice patterns. Ann Emerg Med. 2019. https://doi.org/10.1016/j.annemergmed.2019.08.296.

27.

Hernández-Ramos I, Parra-Esquivel P, López-Hernández Á, Burillo-Putze G. Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome. An Sist Sanit Navar. 2019. https://doi.org/10.23938/ASSN.0635.

28.

Habboushe J, Sedor J. Cannabinoid hyperemesis acute renal failure: a common sequela of cannabinoid hyperemesis syndrome. Am J Emerg Med. 2014. https://doi.org/10.1016/j.ajem.2013.12.013.

Title: Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review
Authors: Julien Flament
Nathan Scius
Henri Thonon
Publication date: 01-12-2020
Publisher: Springer Berlin Heidelberg
Keywords: Hyperemesis Gravidarum
Cannabinoid
Vomiting
Published in: International Journal of Emergency Medicine / Issue 1/2020
Print ISSN: 1865-1372
Electronic ISSN: 1865-1380
DOI: https://doi.org/10.1186/s12245-020-00311-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review

Abstract

Background

Case presentation

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2020

Performance of a three-level triage scale in live triage encounters in an emergency department in Hong Kong

Correction to: Evolution of emergency medical services in the Kingdom of Bahrain

Position within the hospital and role in the emergency department of emergency physicians in the Netherlands: a national survey

Development of an interactive curriculum and trainee-specific preparedness plan for emergency medicine residents

Cerebrospinal fluid findings and hypernatremia in COVID-19 patients with altered mental status

Experience repatriation of citizens from epicentre using commercial flights during COVID-19 pandemic